Aims: To evaluate the relationship between inflammatory biomarkers and lipid
parameters in a Tunisian coronary artery disease group. Material and Methods: In
the study, we have included 122 subjects with acute coronary syndrome (ACS) confirmed
by coronary angiography, selected among patients admitted to the cardiology department
and 162 subjects free of any cardiovascular disease, recruited from medical and
paramedical volunteers. Lipid parameters, high sensitivity CRP (hsCRP) and proinflammatory
cytokines (IL6, IL8 and TNFα) were determined
for all patients and controls. Results: A highly significant difference (P <
10﹣3) was noted between the mean of the hsCRP in coronary
patients (14.65 ± 9.81 mg/L) compared to controls (1.63 ± 1.75 mg/L). We
note also a significant difference between the means of IL6 in the diseased population
(11.56 ± 8.23 pg/mL) compared to controls (2.5 ± 0.84 pg/mL) with a value
of P < 10﹣3. The hsCRP values are inversely correlated with the
HDLc values. No association was found between IL 8 and the various lipid parameters.
Patients having high IL6 values had higher levels of CT and CT/HDLc ratio. This
correlation is statistically significant. Regarding TNFα, there is a positive and significant correlation with CT and LDLc.
Conclusion: Significant correlation was found between inflammatory markers and lipids
profile. This may explain the role of inflammation in the development of cardiovascular
disease.
Cite this paper
Sendesni, R. , Lahidheb, D. , Ayoub, M. , Grira, N. , Lafi, D. , Stambouli, N. , Oudi, M. E. , Ghazouani, E. , Haouala, H. , Aouni, Z. and Mazigh, C. (2016). Correlation between Inflammatory Markers and Lipid Parameters in a Tunisian Coronary Artery Disease Group. Open Access Library Journal, 3, e2635. doi: http://dx.doi.org/10.4236/oalib.1102635.
Baudin, B., Cohena, A., Garcias, F.B., Meuleman, C., Dufaitre, G., Ederhy, S., et al.(2009)
Données épidémiologiques des maladies cardiovasculaires et prise en charge des accidents
cardiovasculaires. Revue Francaise des
Laboratoires, 409, 27-39. http://dx.doi.org/10.1016/s1773-035x(09)70198-4
Madjid, M.
and Willerson, J.T. (2011) Inflammatory Markers in Coronary Heart
Disease. British Medical Bulletin, 100, 23-38. http://dx.doi.org/10.1093/bmb/ldr043
Sukhija, R., Fahdi, I., Garza, L., Fink, L., Scott, M., Aude, W., et al. (2007) Inflammatory Markers, Angiographic Severity
of Coronary Artery Disease, and Patient Outcome. American Journal of Cardiology, 99, 879-884. http://dx.doi.org/10.1016/j.amjcard.2006.11.032
De Gennaro, L., Brunetti, N.D., Montrone, D., De Rosa, F., Cuculo, A. and Di Biase, M. (2012)
Subacute Inflammatory Activation in Subjects with
Acute Coronary Syndrome and Left Ventricular Dysfunction. Inflammation, 35, 363-370. http://dx.doi.org/10.1007/s10753-011-9326-4
Lai, C.L., Ji, Y.R., Liu, X.H., Xing, J.P. and Zhao, J.Q. (2012)
Relationship between Coronary Atherosclerosis Plaque
Characteristics and High Sensitivity C-Reactive Proteins, Interleukin-6. Chinese
Medical Journal (England), 124, 2452-2456.
Scharnagl, H., Stojakovic, T., Weihrauch, G., Winkelmann, R.B., Boehm, B.O.
and Maerz, W. (2010) Interleukin-6 Is Stronger Associated with
All-Cause and Cardiovascularmortality than C-Reactive Protein, Serum Amyloid A and
Fibrinogen (the Luric Study). Atherosclerosis Supplements, 11, 42. http://dx.doi.org/10.1016/S1567-5688(10)70191-4
Fan, Z.X., Hua, Q., Li, Y.P., Liu, R.K. and Yang, Z. (2011)
Interleukin-6, But Not Soluble Adhesion Molecules,
Predicts a Subsequent Mortality from Cardiovascular Disease in Patients with Acute
ST Segment Elevation Myocardial
Infarction. Cell Biochemistry and Biophysics, 61, 443-448. http://dx.doi.org/10.1007/s12013-011-9209-1
Armstrong, E.J., Morrow, D.A.
and Sabatine, M.S. (2006) Inflammatory
Biomarkers in Acute Coronary Syndromes Part I: Introduction and Cytokines. Circulation, 113, 72-75. http://dx.doi.org/10.1161/CIRCULATIONAHA.105.595520
Wang, X.H., Liu, S.Q., Wang, Y.L. and Jin, Y. (2014) Correlation of Serum High-Sensitivity C-Reactive
Protein and Interleukin-6 in Patients with Acute Coronary Syndrome. Genetics
and Molecular Research, 13, 4260-4266. http://dx.doi.org/10.4238/2014.June.9.11
Skoog, T., Dichtl, W., Boquist, S., Skoglund-Andersson, C., Karpe, F., Tang, R., et al. (2002)
Plasma Tumour Necrosis Factor-Alpha and Early Carotid Atherosclerosis in Healthy
Middle-Aged Men. European Heart Journal, 23, 376-383. http://dx.doi.org/10.1053/euhj.2001.2805
Harris, T.B., Ferrucci, L., Tracy, R.P., Corti, M.C., Wacholder, S., Ettinger Jr., W.H., et al. (1999) Associations of Elevated Interleukin-6 and C-Reactive Protein Levels with
Mortality in the Elderly. American
Journal of Medicine, 106, 506-512. http://dx.doi.org/10.1016/S0002-9343(99)00066-2
Ridker, P.M., Hennekens, C.H., Buring, J.E. and Rifai, N. (2000)
C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular
Disease in Women. The New England Journal of Medicine, 342, 836-843. http://dx.doi.org/10.1056/NEJM200003233421202
Onat, A., Can, G.
and Hergenc, G. (2008) Serum C-Reactive Protein Is an
Independent Risk Factor Predicting Cardio- metabolic Risk. Metabolism, 57, 207-214. http://dx.doi.org/10.1016/j.metabol.2007.09.002
Li, J.J. and Fang, C.H. (2004) C-Reactive Protein Is Not Only an
Inflammatory Marker but Also a Direct Cause of Cardiovascular Disease. Medical
Hypotheses, 62, 499-506. http://dx.doi.org/10.1016/j.mehy.2003.12.014
Chang, M.K., Binder, C.J., Torzewski, M. and Witztum, J.L. (2002) C-Reactive Protein Binds to Both Oxidized
LDL and Apoptotic Cells through Recognition of a Common Ligand:
Phosphorylcholine of Oxidized Phospholipids.Pro- ceedings
of the National Academy of Sciences of the United States of America, 99, 13043-13048. http://dx.doi.org/10.1073/pnas.192399699
Zwaka, T.P., Hombach, V. and Torzewski, J. (2001) C-Reactive Protein-Mediated Low
Density Lipoprotein Uptake by Macrophages: Implications for Atherosclerosis. Circulation, 103, 1194-1197. http://dx.doi.org/10.1161/01.CIR.103.9.1194
Venugopal, S.K., Devaraj, S., Yuhanna, I., Shaul, P. and Jialal, I. (2002) Demonstration That C-Reactive Protein
Decreases eNOS Expression and Bioactivity in Human Aortic Endothelial Cells. Circulation, 106, 1439-1441. http://dx.doi.org/10.1161/01.CIR.0000033116.22237.F9
Devaraj, S., Xu, D.Y. and Jialal, I. (2003) C-Reactive Protein Increases
Plasminogen Activator Inhibitor-1 Expression and Activity in Human Aortic
Endothelial Cells: Implications for the Metabolic Syndrome and Atherothrombosis. Circulation, 107, 398-404. http://dx.doi.org/10.1161/01.CIR.0000052617.91920.FD
Tehrani, D.M., Gardin, J.M., Yanez, D., Hirsch, C.H., Lloyd-Jones, D.M., Stein, P.K., et al. (2013) Impact of Inflammatory Biomarkers on Relation of High Density
Lipoprotein-Cholesterol with Incident Coronary Heart Disease: Cardiovascular
Health Study. Atherosclerosis, 231, 246-251. http://dx.doi.org/10.1016/j.atherosclerosis.2013.08.036
Calabresi, L., Gomaraschi, M., Villa, B., Omoboni, L., Dmitrieff, C. and Franceschini, G. (2002) Elevated Soluble Cellular Adhesion Molecules in
Subjects with Low HDL-Cholesterol. Arteriosclerosis, Thrombosis, and Vascular Biology, 22, 656-661. http://dx.doi.org/10.1161/hq0402.105901
Mascarenhas-Melo, F., Sereno, J., Teixeira-Lemos, E., Marado, D., Palavra, F., Pinto, R., et al. (2013) Implication of Low HDL-c Levels in Patients with Average LDL-c Levels: A
Focus on Oxidized LDL, Large HDL Subpopulation, and Adiponectin. Mediators
of Inflammation, 2013, Article
ID:
612038. http://dx.doi.org/10.1155/2013/612038
Wu, D.M., Chu, N.F., Shen, M.H. and Chang, J.B. (2003) Plasma C-Reactive Protein Levels and
Their Relationship to Anthropometric and Lipid Characteristics among Children. Journal
of Clinical Epidemiology, 56, 94-100. http://dx.doi.org/10.1016/S0895-4356(02)00519-X
Demimbras, B., Guler, S., Cakir, B., Chulha, C. and Aral, Y. (2002) Plasma TNF-α Levels and Insulin Resistance in Non Diabetic
Hypertensive Subjects. Hormone Research in Paediatrics, 58, 283-286. http://dx.doi.org/10.1159/000066447
Jovinge, S., Hamsten, A., Torvall, P., Proudler, A., Bavenholm, P., Ericsson, C.G., et al. (1998)
Evidence for a Role of Tumor Necrosis Factor Alpha in Disturbances of
Triglyceride and Glucose Metabolism Predisposing to Coronary Heart Disease. Metabolism, 47, 113-118. http://dx.doi.org/10.1016/S0026-0495(98)90203-7
Chen, X., Xun, K., Chen, L. and Wang, Y.
(2009) TNF-α, a Potent Lipid Metabolism Regulator. Cell
Bioche- mistry
and Function, 27, 407-416. http://dx.doi.org/10.1002/cbf.1596
Popa, C., Netea, M.G., van Riel, P.L., Van Der Meer, J.W. and Stalenhoef, A.F. (2007) The Role of TNF-α in Chronic Inflammatory Conditions, Intermediary Metabolism, and
Cardiovascular Risk. The Journal of Lipid Research, 48, 751- 762. http://dx.doi.org/10.1194/jlr.R600021-JLR200
Vijaya, B.M., Prabhakara, R.P. and Balu, M.K. (2015) Correlative
Association of Interleukin-6 with Malondialdehyde in Prehypertensive and
Hypertensive Subjects. IOSR-JDMS, 14, 53-57.
Jin, W., Sun, G.S., Marchadier, D., Octtaviani, E., Glick, J.M. and Rader, D.J. (2003) Endothelial Cells Secrete Triglycerides
Lipase and Phospolipase Activities in Response to Cytokines as a Result of
Endothelial Lipase. Circulation Research, 92, 644-650. http://dx.doi.org/10.1161/01.RES.0000064502.47539.6D
